Updated:
Prima-Temp
Prima-Temp, a Boulder-based digital health firm, develops a wearable platform using continuous core body temperature and AI for women's health.
Prima-Temp
Prima-Temp, headquartered in Boulder, Colorado, develops digital health technology centered on continuous core body temperature (CCBT) as a circadian biomarker. The firm states its mission is to transform healthcare for women using science-based tools, continuous data tracking, and community engagement (per the firm, 2023). The company's strategy combines hardware — a wearable for continuous temperature monitoring — with a mobile platform that applies AI to identify predictive physiological patterns. Its first application, the Priya Personal Fertility System, targets ovulation prediction and clinical diagnostic support. Future applications under research include metabolic disorders and menopause. The firm also acquired the Kindara Fertility Tracker, an app with 140,000 community members and 95 million days of health data, which informs its clinical roadmap (per the firm, 2023). Prima-Temp's geographic focus is primarily North America, with remote clinical trial capabilities. Prima-Temp has not disclosed total funding, AUM, or team size. The firm has completed telemedicine-executed clinical trials testing its wearable device for remote monitoring. No additional offices, philanthropic arms, or operating companies have been made public. No recent operational events (within the last 24 months) are available from public sources. A structural differentiator is Prima-Temp's focus on CCBT as a proprietary biomarker platform rather than a single product. The firm's strategy integrates data from an existing user community and applies AI to derive clinical insights, positioning it as a data-driven women's health company rather than a pure device manufacturer.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boulder
Corporate office
Boulder, CO, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Prima-Temp?
Prima-Temp has not publicly named a CEO, CIO, or investment decision-maker in available sources. The firm's website focuses on its scientific and product leadership rather than financial or executive roles. Institutional allocators would need direct sourcing to determine who controls capital allocation.
How does Prima-Temp source proprietary deal flow?
Prima-Temp appears to operate as a product development company rather than a traditional investor. It sources clinical opportunities through its own research into CCBT applications for fertility, metabolic disorders, and menopause. The firm also leverages data from the Kindara community to identify patterns that inform its product roadmap (per the firm, 2023).
Is Prima-Temp structured as a single family office or does it operate more like a venture firm?
Prima-Temp is not classified as a family office in any public source. The firm describes its operations as a digital health technology company developing wearable solutions and AI-driven clinical tools. No evidence suggests it operates as an investment vehicle for external or family capital.
What investment stages does Prima-Temp typically target?
Prima-Temp has not disclosed an investment strategy or target stage. The firm focuses on product development for women's health applications, including fertility and menopause. No public information indicates commitments to external funds or direct equity deals beyond its own operations.
Which sectors does Prima-Temp explicitly avoid?
Prima-Temp has not published any prohibited sectors. Based on its public materials, the firm concentrates exclusively on women's health and digital health applications of CCBT. No evidence suggests involvement in other asset classes or geographies.
Does Prima-Temp maintain philanthropic structures, and how are they separated?
Prima-Temp has not disclosed any philanthropic foundations or separate charitable vehicles in available public records. The firm's operations appear limited to its commercial digital health platform and clinical research activities.
What is Prima-Temp's known posture on co-investments alongside external GPs?
There is no public record of Prima-Temp participating in co-investments or partnering with external general partners. The firm's activities center on its own product development and clinical trials, not on deploying capital alongside third-party managers.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: